Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation

Yeriel Estrada, Jianli Dong, Liliana Ossowski

Research output: Chapter in Book/Report/Conference proceedingChapter

40 Citations (Scopus)

Abstract

Melanoma is one of the most therapy-resistant cancers. Activating mutations in BRAF and NRAS are the source of extracellular signal regulated protein kinase (ERK) pathway activation. We show that melanoma cell lines, originating in different metastatic sites, with BRAF or NRAS mutations, in addition to active mitogen activated protein kinase (MAPK)-ERK, also have highly activated stress activated protein kinase (SAPK)-p38. This is in direct contrast to carcinoma cells in which the activity of the two kinases appears to be mutually exclusive; high level of p38 activity inhibits, through a negative feedback, ERK activity and prevents tumorigenesis. Melanomas are insensitive to ERK inhibition by p38 and utilize p38-signaling pathway for migration and growth in vivo. We found a positive functional loop linking the high ERK activity to surface expression of αVβ3-integrin. This integrin, by interacting with vitronectin, induces p38 activity and increases IL-8 production, enhancing cell migration. Because the negative loop from p38 to ERK is lost, the two kinases can remain simultaneously activated. Inhibition of ERK and p38 activities is more effective in blocking in vivo growth than inhibition of each kinase individually. Future therapies might have to consider targeting of both pathways.

Original languageEnglish (US)
Title of host publicationPigment Cell and Melanoma Research
Pages66-76
Number of pages11
Volume22
Edition1
DOIs
StatePublished - Feb 2009

Fingerprint

Crosstalk
Melanoma
Phosphotransferases
Integrins
Protein Kinases
Cells
Vitronectin
Mutation
MAP Kinase Signaling System
Extracellular Signal-Regulated MAP Kinases
p38 Mitogen-Activated Protein Kinases
Growth
Heat-Shock Proteins
Mitogen-Activated Protein Kinases
Interleukin-8
Cell Movement
Carcinogenesis
Chemical activation
Carcinoma
Feedback

Keywords

  • ERK
  • IL-8
  • In vivo growth
  • Integrin
  • Melanoma
  • Migration
  • P38

ASJC Scopus subject areas

  • Dermatology
  • Oncology
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Estrada, Y., Dong, J., & Ossowski, L. (2009). Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation. In Pigment Cell and Melanoma Research (1 ed., Vol. 22, pp. 66-76) https://doi.org/10.1111/j.1755-148X.2008.00520.x

Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation. / Estrada, Yeriel; Dong, Jianli; Ossowski, Liliana.

Pigment Cell and Melanoma Research. Vol. 22 1. ed. 2009. p. 66-76.

Research output: Chapter in Book/Report/Conference proceedingChapter

Estrada, Yeriel ; Dong, Jianli ; Ossowski, Liliana. / Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation. Pigment Cell and Melanoma Research. Vol. 22 1. ed. 2009. pp. 66-76
@inbook{518c74c880e44f8485c238673add5230,
title = "Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation",
abstract = "Melanoma is one of the most therapy-resistant cancers. Activating mutations in BRAF and NRAS are the source of extracellular signal regulated protein kinase (ERK) pathway activation. We show that melanoma cell lines, originating in different metastatic sites, with BRAF or NRAS mutations, in addition to active mitogen activated protein kinase (MAPK)-ERK, also have highly activated stress activated protein kinase (SAPK)-p38. This is in direct contrast to carcinoma cells in which the activity of the two kinases appears to be mutually exclusive; high level of p38 activity inhibits, through a negative feedback, ERK activity and prevents tumorigenesis. Melanomas are insensitive to ERK inhibition by p38 and utilize p38-signaling pathway for migration and growth in vivo. We found a positive functional loop linking the high ERK activity to surface expression of αVβ3-integrin. This integrin, by interacting with vitronectin, induces p38 activity and increases IL-8 production, enhancing cell migration. Because the negative loop from p38 to ERK is lost, the two kinases can remain simultaneously activated. Inhibition of ERK and p38 activities is more effective in blocking in vivo growth than inhibition of each kinase individually. Future therapies might have to consider targeting of both pathways.",
keywords = "ERK, IL-8, In vivo growth, Integrin, Melanoma, Migration, P38",
author = "Yeriel Estrada and Jianli Dong and Liliana Ossowski",
year = "2009",
month = "2",
doi = "10.1111/j.1755-148X.2008.00520.x",
language = "English (US)",
volume = "22",
pages = "66--76",
booktitle = "Pigment Cell and Melanoma Research",
edition = "1",

}

TY - CHAP

T1 - Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation

AU - Estrada, Yeriel

AU - Dong, Jianli

AU - Ossowski, Liliana

PY - 2009/2

Y1 - 2009/2

N2 - Melanoma is one of the most therapy-resistant cancers. Activating mutations in BRAF and NRAS are the source of extracellular signal regulated protein kinase (ERK) pathway activation. We show that melanoma cell lines, originating in different metastatic sites, with BRAF or NRAS mutations, in addition to active mitogen activated protein kinase (MAPK)-ERK, also have highly activated stress activated protein kinase (SAPK)-p38. This is in direct contrast to carcinoma cells in which the activity of the two kinases appears to be mutually exclusive; high level of p38 activity inhibits, through a negative feedback, ERK activity and prevents tumorigenesis. Melanomas are insensitive to ERK inhibition by p38 and utilize p38-signaling pathway for migration and growth in vivo. We found a positive functional loop linking the high ERK activity to surface expression of αVβ3-integrin. This integrin, by interacting with vitronectin, induces p38 activity and increases IL-8 production, enhancing cell migration. Because the negative loop from p38 to ERK is lost, the two kinases can remain simultaneously activated. Inhibition of ERK and p38 activities is more effective in blocking in vivo growth than inhibition of each kinase individually. Future therapies might have to consider targeting of both pathways.

AB - Melanoma is one of the most therapy-resistant cancers. Activating mutations in BRAF and NRAS are the source of extracellular signal regulated protein kinase (ERK) pathway activation. We show that melanoma cell lines, originating in different metastatic sites, with BRAF or NRAS mutations, in addition to active mitogen activated protein kinase (MAPK)-ERK, also have highly activated stress activated protein kinase (SAPK)-p38. This is in direct contrast to carcinoma cells in which the activity of the two kinases appears to be mutually exclusive; high level of p38 activity inhibits, through a negative feedback, ERK activity and prevents tumorigenesis. Melanomas are insensitive to ERK inhibition by p38 and utilize p38-signaling pathway for migration and growth in vivo. We found a positive functional loop linking the high ERK activity to surface expression of αVβ3-integrin. This integrin, by interacting with vitronectin, induces p38 activity and increases IL-8 production, enhancing cell migration. Because the negative loop from p38 to ERK is lost, the two kinases can remain simultaneously activated. Inhibition of ERK and p38 activities is more effective in blocking in vivo growth than inhibition of each kinase individually. Future therapies might have to consider targeting of both pathways.

KW - ERK

KW - IL-8

KW - In vivo growth

KW - Integrin

KW - Melanoma

KW - Migration

KW - P38

UR - http://www.scopus.com/inward/record.url?scp=58649115386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58649115386&partnerID=8YFLogxK

U2 - 10.1111/j.1755-148X.2008.00520.x

DO - 10.1111/j.1755-148X.2008.00520.x

M3 - Chapter

C2 - 18983537

AN - SCOPUS:58649115386

VL - 22

SP - 66

EP - 76

BT - Pigment Cell and Melanoma Research

ER -